Integrating environmental health and genomics research in Africa: challenges and opportunities identified during a Human Heredity and Health in Africa (H3Africa) Consortium workshop
Open Access
- 27 August 2019
- journal article
- Published by F1000 Research Ltd in AAS Open Research
- Vol. 2, 159
- https://doi.org/10.12688/aasopenres.12983.1
Abstract
Individuals with African ancestry have extensive genomic diversity but have been underrepresented in genomic research. There is also extensive global diversity in the exposome (the totality of human environmental exposures from conception onwards) which should be considered for integrative genomic and environmental health research in Africa. To address current research gaps, we organized a workshop on environmental health research in Africa in conjunction with the H3Africa Consortium and the African Society of Human Genetics meetings in Kigali, Rwanda. The workshop was open to all researchers with an interest in environmental health in Africa and involved presentations from experts within and outside of the Consortium. This workshop highlighted innovative research occurring on the African continent related to environmental health and the interplay between the environment and the human genome. Stories of success, challenges, and collaborative opportunities were discussed through presentations, breakout sessions, poster presentations, and a panel discussion. The workshop informed participants about environmental risk factors that can be incorporated into current or future epidemiology studies and addressed research design considerations, biospecimen collection and storage, biomarkers for measuring chemical exposures, laboratory strategies, and statistical methodologies. Inclusion of environmental exposure measurements with genomic data, including but not limited to H3Africa projects, can offer a strong platform for building gene-environment (G x E) research in Africa. Opportunities to leverage existing resources and add environmental exposure data for ongoing and planned studies were discussed. Future directions include expanding the measurement of both genomic and exposomic risk factors and incorporating sophisticated statistical approaches for analyzing high dimensional G x E data. A better understanding of how environmental and genomic factors interact with nutrition and infection is also needed. Considering that the environment represents many modifiable risk factors, these research findings can inform intervention and prevention efforts towards improving global health.Keywords
Funding Information
- National Institutes of Health
- National Institute of Environmental Health Sciences
- Wellcome Trust
This publication has 31 references indexed in Scilit:
- Cohort Profile: African Collaborative Center for Microbiome and Genomics Research’s (ACCME's) Human Papillomavirus (HPV) and Cervical Cancer StudyInternational Journal of Epidemiology, 2017
- Independent and combined effects of maternal smoking and solid fuel on infant and child mortality in sub‐Saharan AfricaTropical Medicine & International Health, 2016
- Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health StudyThe Lancet Respiratory Medicine, 2016
- H3ABioNet, a sustainable pan-African bioinformatics network for human heredity and health in AfricaGenome Research, 2015
- Human Heredity and Health (H3) in Africa Kidney Disease Research NetworkClinical Journal of the American Society of Nephrology, 2015
- Understanding the rise in cardiovascular diseases in Africa: harmonising H3Africa genomic epidemiological teams and toolsCardioVascular Journal of Africa, 2014
- Enabling the genomic revolution in AfricaScience, 2014
- H3Africa: a tipping point for a revolution in bioinformatics, genomics and health research in AfricaSource Code for Biology and Medicine, 2014
- Paving the Way Towards a Successful and Fulfilling Career in Computational BiologyPLoS Computational Biology, 2014
- Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow NationCurrent Pharmacogenomics and Personalized Medicine, 2011